The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study for prostate cancer monitoring using 18F-DCFPyL and blood-based biomarkers.
 
Emerson A. Lim
No Relationships to Disclose
 
Akiva Mintz
Consulting or Advisory Role - Philips Healthcare; Regeneron
Research Funding - Caelum Biosciences
Travel, Accommodations, Expenses - Siemens
 
Mark N. Stein
Consulting or Advisory Role - Exelixis; Exelixis; Merck Sharp & Dohme
Research Funding - Advaxis (Inst); Bristol-Myers Squibb (Inst); Genocea Biosciences (Inst); Harpoon (Inst); Janssen Oncology (Inst); Lilly (Inst); Medivation/Astellas (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Oncoceutics (Inst); Seagen (Inst); Suzhou Kintor Pharmaceuticals (Inst); Xencor (Inst)
 
Alex J. Rai
Consulting or Advisory Role - Quest Diagnostics
 
Mahesh M. Mansukhani
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
David Henry Aggen
Consulting or Advisory Role - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - University of Illinois - Urbana Champaign
 
Matthew Dallos
No Relationships to Disclose
 
Jessica Hawley
No Relationships to Disclose
 
Hiram A Shaish
No Relationships to Disclose
 
Lawrence Howard Schwartz
Consulting or Advisory Role - Novartis; Roche
Research Funding - Daiichi Sankyo (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Millenium Pharamceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Varian Medical Systems
 
Charles G. Drake
Stock and Other Ownership Interests - Compugen; ImmunExcite; NexImmune; Potenza Therapeutics; Tizona Therapeutics, Inc.
Consulting or Advisory Role - Agenus; Astellas Medivation; AstraZeneca/MedImmune; Bristol-Myers Squibb (Inst); Compugen; Dendreon; ImmuneXcite; Janssen Oncology; Lilly; Merck; NexImmune; Pfizer; Pierre Fabre; Potenza Therapeutics; Roche/Genentech; Tizona Therapeutics, Inc.
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); Compugen (Inst); Janssen Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Patents licensed to BMS (Inst); Patents licensed to Potenza Therapeutics (Inst)